Individuals involved in drafting clinical practice guidelines are charged by American Pain Society (APS) with the responsibility to develop objective, complete, and balanced guidelines. Financial relationships with commercial companies could conflict with the responsibility when the company's products or services are related to the subject of the guideline. To ensure the integrity of APS and the Clinical Practice Guidelines Program, all participants in the development of clinical practice guidelines must submit a Conflict of Interest Disclosure Form to APS prior to participation in any guideline development activity.
All members of the Cancer Pain Management Guideline Panel have submitted Conflict of Interest Disclosure forms that have been reviewed by the APS Executive Director, who has determined no conflict of interest exists with any individual panel member. In addition, panel members disclosed financial relationships with commercial companies to all other panel members during panel meetings.
Individual panel members currently have or during the past 3 years have had relationships with the following pharmaceutical or biotechnology companies:
Christine Miaskowski. Research grants: Purdue Pharma L.P., Janssen Pharmaceutica, Endo Pharmaceuticals, Inc., Amgen; Speakers' Bureau: Purdue Pharma L.P., Abbott Laboratories, Janssen Pharmaceutica, Endo Pharmaceuticals, Inc., Alza, Ortho Biotech, Merck and Co., Inc.
James Cleary. Research grants: Purdue Pharma L.P., Anesta, Endo Pharmaceuticals, Inc.; Speakers' Bureau: Purdue Pharma L.P., Roxane Laboratories, Inc., Cephalon.
Patrick Coyne. Speakers' Bureau: Purdue Pharma L.P., Janssen Pharmaceutica.
Rebecca Finley. Research grant: Merck and Co., Inc.; Speakers' Bureau: Purdue Pharma L.P.
Roxie Foster. Development grant: Abbott Laboratories; Speakers' Bureau: Abbott Laboratories, Astra.
Nora Janjan. Research grants: Siemens, Ortho Biotech; Protocol panels: Alza, Johnson and Johnson, Medtronic.
Karen Syrjala. Research grants: Roxane Laboratories, Inc., Microsoft; Consultant: Roxane Laboratories, Inc., Microsoft; Speakers' Bureau: Janssen Pharmaceutica.
Steve Weisman. Research grants: Alza, Janssen Pharmaceutica, Endo Pharmaceuticals, Inc.; Consultant: Alza, Janssen Pharmaceutica, Cephalon.
Ada Jacox and Carol Spengler, APS staff and consultants. Funding from the APS Guidelines Program Fund.